BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nymox Pharmaceutical Corporation 

175 Bouchard, Suite 100

Dorval  Quebec  H9S 1B1  Canada
Phone: 514-636-3122 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Nymox Pharmaceutical (NYMX) Announces Positive Prostate Cancer 8 Month Clinical Trial Results 9/10/2014 8:13:22 AM
Nymox Pharmaceutical (NYMX) Reports Second Quarter 2014 Financial Results 8/11/2014 7:52:01 AM
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014 7:35:45 AM
Nymox Pharmaceutical (NYMX) Announces Completion Of Enrollment For Second BPH Re-Injection Study 7/15/2014 9:16:16 AM
Nymox Pharmaceutical (NYMX) Reports Positive Update On Nerve Sparing And Sexual Function Preservation In Men Treated With NX-1207 6/17/2014 9:06:23 AM
Nymox Pharmaceutical (NYMX) Reports Positive New Safety Study Data For Phase 3 BPH Drug 6/12/2014 7:21:35 AM
Nymox Pharmaceutical (NYMX) Reports New Results On Favorable Side Effect Profile Of NX-1207 Treatment 5/21/2014 9:13:54 AM
Nymox Pharmaceutical (NYMX) Reports First Quarter 2014 Financial Results 5/15/2014 11:50:38 AM
Nymox Pharmaceutical (NYMX) Reports Positive Results Showing That NX-1207 Treatment For Prostate Cancer Does Not Affect Testosterone Levels 5/13/2014 11:37:32 AM
Nymox Pharmaceutical (NYMX) Announces Completion Of Second Pivotal Phase 3 NX-1207 Trial For BPH 5/8/2014 9:11:35 AM
12345678910...